|
Volumn 19, Issue 3, 2001, Pages 171-175
|
A double-blind, placebo-controlled, and randomized study of loratadine (clarityne) syrup for the treatment of allergic rhinitis in children aged 3 to 12 years
a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIHISTAMINIC AGENT;
LORATADINE;
PLACEBO;
ALLERGIC RHINITIS;
ARTICLE;
CHILDHOOD DISEASE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DERMATOPHAGOIDES PTERONYSSINUS;
DISEASE SEVERITY;
DOSE TIME EFFECT RELATION;
DOUBLE BLIND PROCEDURE;
DRUG DOSAGE FORM;
DRUG EFFICACY;
DRUG SAFETY;
EVALUATION;
EYE DISEASE;
FEMALE;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
NONHUMAN;
NOSE CONGESTION;
PARALLEL DESIGN;
PARENT;
PATIENT COMPLIANCE;
PHYSICIAN;
PRURITUS;
RANDOMIZED CONTROLLED TRIAL;
RHINORRHEA;
SCHOOL CHILD;
SCORING SYSTEM;
SIDE EFFECT;
SNEEZING;
SYMPTOM;
SYRUP;
TASTE AVERSION;
ADMINISTRATION, ORAL;
CHILD;
CHILD, PRESCHOOL;
DOUBLE-BLIND METHOD;
FEMALE;
HISTAMINE H1 ANTAGONISTS;
HUMANS;
LORATADINE;
MALE;
PHARMACEUTICAL SOLUTIONS;
RHINITIS, ALLERGIC, PERENNIAL;
|
EID: 0035681417
PISSN: 0125877X
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (22)
|
References (12)
|